Estia Health Past Earnings Performance

Past criteria checks 0/6

Estia Health's earnings have been declining at an average annual rate of -38.2%, while the Healthcare industry saw earnings growing at 15.3% annually. Revenues have been growing at an average rate of 5.3% per year.

Key information

-38.2%

Earnings growth rate

-38.3%

EPS growth rate

Healthcare Industry Growth	15.7%
Revenue growth rate	5.3%
Return on equity	-6.8%
Net Margin	-4.5%
Last Earnings Update	30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Estia Health makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:26E Revenue, expenses and earnings (AUD Millions)
Date	Revenue	Earnings	G+A Expenses
30 Jun 23	754	-34	45
31 Mar 23	721	-52	44
31 Dec 22	689	-70	44
30 Sep 22	680	-61	42
30 Jun 22	671	-52	41
31 Mar 22	668	-25	39
31 Dec 21	665	3	38
30 Sep 21	656	4	37
30 Jun 21	646	6	36
31 Mar 21	645	-66	35
31 Dec 20	643	-137	34
30 Sep 20	640	-127	34
30 Jun 20	637	-117	34
31 Mar 20	625	-41	37
31 Dec 19	612	35	39
30 Sep 19	599	38	41
30 Jun 19	586	41	42
31 Mar 19	575	42	41
31 Dec 18	565	42	39
30 Sep 18	556	42	38
30 Jun 18	547	41	37
31 Mar 18	540	41	37
31 Dec 17	533	41	36
30 Sep 17	529	41	36
30 Jun 17	525	41	37
31 Mar 17	517	36	35
31 Dec 16	510	31	33
30 Sep 16	476	29	31
30 Jun 16	443	28	30
31 Mar 16	400	27	17
31 Dec 15	357	27	4
30 Sep 15	321	2	12
30 Jun 15	285	-23	19
31 Mar 15	228	-30	29
31 Dec 14	171	-38	39
30 Sep 14	119	-26	23
30 Jun 14	67	-14	6

Quality Earnings: 26E is currently unprofitable.

Growing Profit Margin: 26E is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 26E is unprofitable, and losses have increased over the past 5 years at a rate of 38.2% per year.

Accelerating Growth: Unable to compare 26E's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 26E is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).

Return on Equity

High ROE: 26E has a negative Return on Equity (-6.77%), as it is currently unprofitable.

Estia Health Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Full year 2023 earnings released: AU$0.13 loss per share (vs AU$0.20 loss in FY 2022)

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

Full year 2022 earnings released: AU$0.20 loss per share (vs AU$0.021 profit in FY 2021)

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings released: AU$0.13 loss per share (vs AU$0.20 loss in FY 2022)

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought €68k worth of stock

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Full year 2022 earnings released: AU$0.20 loss per share (vs AU$0.021 profit in FY 2021)

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: €1.22

New 90-day high: €1.13

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

New 90-day high: €0.96

New 90-day low: €0.80

New 90-day low: €0.82

Non-Executive Director recently bought €62k worth of stock

Full year earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Revenue & Expenses Breakdown
Beta